Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on S Diol. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN1212403C reveals a microbial method for high-purity (S)-phenylglycol. Discover cost-effective biocatalysis for reliable chiral intermediate supply chains.
Patent CN102731324B reveals a safer, cost-effective serinol synthesis route using normal-pressure hydrazine reduction, ideal for iopamidol manufacturing.
Patent CN114409505A details a high-yield synthesis of posaconazole intermediate using m-difluorobenzene, offering significant cost and supply chain advantages for API manufacturers.
Patent CN101735300A details a high-yield route for Drospirenone intermediates. Discover cost-effective steroid synthesis and scalable supply chain solutions.
Patent CN111989316B details an efficient synthesis route for pancreatic disease treatment intermediates, offering significant cost reduction and supply chain reliability for global manufacturers.
Patent CN106701723B details FSAA mutants for chiral synthesis. Offers cost reduction in chiral building block manufacturing with high stereoselectivity.
Patent CN1122658C details advanced isoserinol purification achieving ultra-low impurities for contrast agents. Offers supply chain stability and cost reduction in pharmaceutical intermediates manufacturing.
Patent CN113816836A details enzymatic route for liver drug intermediate. High purity, scalable, cost-effective supply chain solution.
Patent CN101234981A details a high-yield synthesis for 2,6-bis(2,4-dinitrophenoxy)naphthalene, offering cost reduction in electronic chemical manufacturing and reliable supply.
Patent CN101234986B details a high-yield synthesis for 1,4-bis(2,4-dinitrophenoxy)naphthalene, a critical monomer for advanced polyimides used in electronics and aerospace applications.
Patent CN110156645B details a streamlined 2-step asymmetric synthesis for florfenicol intermediates, drastically cutting waste and costs while ensuring high optical purity for veterinary pharmaceutical manufacturing supply chains.
Patent CN1013440B details a novel chiral pool synthesis for unnatural ceramides, offering high-purity intermediates for ganglioside manufacturing with improved supply chain reliability.
Patent CN115537405B reveals a high-efficiency ketoreductase mutant for producing chiral pharmaceutical intermediates with superior selectivity and scalable manufacturing potential.
Patent CN110229087B details a novel purification method for thiamphenicol intermediates, offering superior impurity removal and scalable manufacturing capabilities for global supply chains.
Patent CN1188215C reveals novel cobalt-based carbonylation methods for high-purity 1,3-alkanediols. Discover cost-effective synthesis routes for reliable pharmaceutical intermediates supplier partnerships.
Patent CN106350565A details enzymatic production of Ginsenoside Rh2. Discover cost-effective, scalable supply chain solutions for high-purity pharmaceutical intermediates.
Novel NHC-catalyzed synthesis ensures 100% cis-isomer purity for high-performance polyesters. Cost-effective, scalable manufacturing solution for global supply chains.
Patent CN109797174B reveals high-yield ketoreductase route. Reduces heavy metal waste, ensures 100% ee. Ideal for veterinary API supply chains.
Patent CN102154384A reveals efficient recombinant E. coli method yielding >26g/L with >99% ee, offering significant cost and supply chain advantages.
Patent CN1761640A details a novel bismuth-catalyzed oxidative cleavage of vic-diols, offering a safer, high-yield route for agrochemical intermediates and fine chemicals.